INVIVYD, INC. Increase Decrease In Operating Lease Liability
INVIVYD, INC. (IVVD) reported Increase Decrease In Operating Lease Liability of -$532.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- INVIVYD, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$235.00K.
- INVIVYD, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$297.00K.
- INVIVYD, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$182.00K.
- INVIVYD, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$289.00K.
- INVIVYD, INC. increase decrease in operating lease liability for fiscal 2025 was -$1.22M.
- INVIVYD, INC. increase decrease in operating lease liability for fiscal 2024 was -$1.66M.
- INVIVYD, INC. increase decrease in operating lease liability for fiscal 2023 was -$1.56M.
- INVIVYD, INC. increase decrease in operating lease liability for fiscal 2022 was -$475.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$532.00K 10-Q · filed 2026-08-13 | -$714.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.00M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$297.00K 10-Q · filed 2026-05-14 | -$479.00K derived: sum of 2 quarters · filed 2026-05-14 | -$768.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.10M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$471.00K derived: sum of 2 quarters · filed 2026-03-05 | -$808.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.22M 10-K · filed 2026-03-05 | |
| 2025-09-30 | -$289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$626.00K derived: sum of 2 quarters · filed 2026-08-13 | -$1.04M 10-Q · filed 2025-11-06 | -$1.45M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$747.00K 10-Q · filed 2026-08-13 | -$1.16M derived: sum of 3 quarters · filed 2026-08-13 | -$1.58M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$410.00K 10-Q · filed 2026-05-14 | -$826.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.25M derived: sum of 3 quarters · filed 2026-05-14 | -$1.67M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$838.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.26M derived: sum of 3 quarters · filed 2026-03-05 | -$1.66M 10-K · filed 2026-03-05 | |
| 2024-09-30 | -$422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$841.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.25M 10-Q · filed 2025-11-06 | -$1.65M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$825.00K 10-Q · filed 2025-08-14 | -$1.23M derived: sum of 3 quarters · filed 2025-08-14 | -$1.62M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$406.00K 10-Q · filed 2025-05-15 | -$806.00K derived: sum of 2 quarters · filed 2025-05-15 | -$1.20M derived: sum of 3 quarters · filed 2025-05-15 | -$1.58M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$792.00K derived: sum of 2 quarters · filed 2025-03-20 | -$1.18M derived: sum of 3 quarters · filed 2025-03-20 | -$1.56M 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$392.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$778.00K derived: sum of 2 quarters · filed 2024-11-14 | -$1.16M 10-Q · filed 2024-11-14 | -$1.86M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$767.00K 10-Q · filed 2024-08-14 | -$1.46M derived: sum of 3 quarters · filed 2024-08-14 | -$1.03M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$381.00K 10-Q · filed 2024-05-09 | -$1.08M derived: sum of 2 quarters · filed 2024-05-09 | -$642.00K derived: sum of 3 quarters · filed 2024-05-09 | -$787.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$261.00K derived: sum of 2 quarters · filed 2024-03-28 | -$406.00K derived: sum of 3 quarters · filed 2024-03-28 | -$475.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $291.00K derived: sum of 2 quarters · filed 2023-11-09 | $222.00K 10-Q · filed 2023-11-09 | -$222.00K 10-Q · filed 2022-11-10 | $222.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$214.00K 10-Q · filed 2023-08-10 | -$214.00K derived: sum of 3 quarters · filed 2024-02-09 | -$214.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-03-31 | -$69.00K 10-Q · filed 2023-05-11 | -$69.00K derived: sum of 2 quarters · filed 2024-02-09 | -$69.00K derived: sum of 3 quarters · filed 2024-02-09 | -$69.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2021-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2024-02-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-09 | $0.00 8-K · filed 2024-02-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |